NT-proBNP more accurately reflected cardiac status during carperitide (ANP analog) infusion than BNP, because BNP levels are directly affected by the drug while NT-proBNP is not — important for monitoring natriuretic peptide therapy.
Key findingNT-proBNP more accurately reflected cardiac status during carperitide (ANP analog) infusion than BNP, because BNP levels are directly affected by the
What the researchers found
NT-proBNP more accurately reflected cardiac status during carperitide (ANP analog) infusion than BNP, because BNP levels are directly affected by the drug while NT-proBNP is not — important for monitoring natriuretic peptide therapy.
Why it matters
Relevant for peptide research.
How the study worked
research study.
What this study cannot tell us
See abstract.
How to read the evidence
emerging evidence.
When this study was published
Published in 2009.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
Common questions
What was studied?
What was found?
Read the original research
Plasma NT-proBNP as a more reliable biomarker of endogenous cardiac natriuretic peptides than BNP during carperitide infusion.
International heart journal, 50(2), 183-90
Citation
Nishiyama, Keizo; Tsutamoto, Takayoshi; Tanaka, Toshinari; Fujii, Masanori; Yamamoto, Takashi; Yamaji, Masayuki; Horie, Minoru. (2009). Plasma NT-proBNP as a more reliable biomarker of endogenous cardiac natriuretic peptides than BNP during carperitide infusion.. International heart journal, 50(2), 183-90.